Inventor · disambiguated record
Christopher H. Moy
Also filed as: MOY CHRISTOPHER H
2 granted patents·2 pending applications·0 citations·filing 2018–2022
28Inventor score
Files withJANSSEN PHARMACEUTICA NV4
Top patents by PatentIndex Score
4 records- 0168US11999993B2Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jun 4, 2024·0 cites·8 claims
- 0257US11279970B2Use of biomarkers in identifying cancer patients that will be responsive to treatment with a PRMT5 inhibitorJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 22, 2022·0 cites·8 claims
- 0350US2025000858A1Fgfr tyrosine kinase inhibitors for the treatment of advanced solid tumorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 0443US2023321087A1Fgfr inhibitor combination therapiesJANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →